Digital-Analog Intervention for Chronic Kidney Disease
(KIDNEYTIME+ Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new approach to help people access living-donor kidney transplants. It compares a digital tool, KidneyTIME+, used with or without a human guide, to determine which is more effective at helping patients learn about and reach out for donor kidneys. Those referred to a transplant center and considering kidney transplants might be a good fit for this trial. Participants will use the tool to explore their options and improve their chances of finding a kidney donor. As an unphased trial, this study provides participants the opportunity to explore innovative methods for increasing their chances of finding a kidney donor.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that KidneyTIME+, a digital and in-person program, is designed to be safe. This program uses animated videos to educate patients and potential donors about living-donor kidney transplants. By focusing on education and outreach through mobile technology, it avoids the risks associated with drugs or surgeries.
No specific reports of negative effects have emerged from using KidneyTIME+. This program is part of the KidneyTIME-2 initiative, which helps patients learn about donor options. In this trial, some participants receive additional support from individuals, but the primary focus remains on education.
The study is labeled as "Not Applicable" for a phase, indicating it likely does not test a new drug or risky procedure, further supporting its safety.12345Why are researchers excited about this trial?
Researchers are excited about the KidneyTIME+ intervention because it leverages digital technology to enhance education and outreach around living donor kidney transplantation. Unlike traditional methods that rely heavily on routine clinical support, KidneyTIME+ offers a mobile-based platform, KidneyTime-2, which empowers patients and their networks to independently learn and engage potential donors. A unique feature of this intervention is the option for human guide support, available over six months, which helps users navigate the platform and maximize its benefits. This combination of digital and personalized support aims to increase the accessibility and effectiveness of living donor kidney transplantation education, potentially leading to better patient outcomes.
What evidence suggests that this trial's treatments could be effective for increasing living-donor kidney transplant access?
Research has shown that tools like KidneyTIME+ can increase the number of living-donor kidney transplants. In this trial, participants will join one of two groups: one will use KidneyTIME-2 without human support, while the other will use it with human support. Studies have found that patients using mobile education tools, such as KidneyTIME+, often learn more and actively seek donors. People generally view these educational tools positively, as they help clarify the living kidney donation process. Additionally, those who receive kidney transplants tend to live longer than those who remain on dialysis, highlighting the importance of increasing transplant access. Overall, KidneyTIME+ aims to educate and support patients, potentially leading to better health outcomes.26789
Are You a Good Fit for This Trial?
This trial is for patients with chronic kidney issues or those seeking a kidney transplant. It's open to individuals being evaluated at a specific transplant center. Participants must consent and undergo an initial assessment, but details on specific inclusion and exclusion criteria are not provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the KidneyTIME+ intervention with or without human guide support, including video education and donor outreach materials
Follow-up
Participants are monitored for donor inquiries and outreach behaviors, and complete surveys to assess intervention impact
Long-term Follow-up
Assessment of time to waiting-list placement and additional follow-up measures
What Are the Treatments Tested in This Trial?
Interventions
- KidneyTIME+
Trial Overview
The study compares two approaches to increase access to living-donor kidney transplants: one using only digital education (KidneyTIME+) and the other combining digital education with personal guidance from a human guide. Patients are randomly assigned to either group.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
KidneyTIME-2 is a multicomponent mobile education-outreach intervention to increase patient- and network-to-donor self-learning and outreach, about living donor kidney transplantation. Human guide support offered over a 6 month period to encourage use of the intervention and donor outreach.
KidneyTime-2 is a multicomponent mobile education-outreach intervention to increase patient- and network-to-donor self-learning and outreach, about living donor kidney transplantation. Routine clinical support from non-study sources through usual Transplant Center protocols including clinic provider communications.
Find a Clinic Near You
Who Is Running the Clinical Trial?
State University of New York at Buffalo
Lead Sponsor
Citations
Digital-Analog Intervention for Chronic Kidney Disease ...
Trial Overview The study compares two approaches to increase access to living-donor kidney transplants: one using only digital education (KidneyTIME+) and the ...
Comparison of outcomes of chronic kidney disease based ...
Post-hoc study of a clinical trial showed that those patients with PKD had a higher risk of kidney failure and a lower risk of death than those with CKD with ...
3.
researchgate.net
researchgate.net/publication/363596198_Patient_perceptions_by_race_of_educational_animations_about_living_kidney_donation_made_for_a_diverse_populationPatient perceptions by race of educational animations ...
Methods We conducted a secondary analysis of 88 transcripts derived from interviews and focus groups conducted with diverse target users (62 kidney failure ...
Selection Patterns and Outcomes of Kidney ...
The 78% 5-year survival in kidney transplant recipients demonstrates outcomes achievable with careful selection, while the 21% 5-year survival in dialysis ...
Predicting outcomes in chronic kidney disease: needs and ...
Guidelines recommend that nephrologists use clinical prediction models (CPMs) to help identify patients at increased risk of CKD progression and ...
NCT07072767 | Hybrid Dissemination Study of A Digital ...
KidneyTIME+ is a digital-analog intervention with human support. It is based on animated video education targeted to patients, donors, and ...
Diagnostic Validity of Chronic Kidney Disease in Health ...
Our results indicate that the detection of older CKD patients may perform better and may yield a higher validity in more recent German claims ...
Preventing chronic kidney disease and maintaining ...
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease.
The Impact of Early-to-Moderate Stage Chronic Kidney ...
Multivariate analysis revealed that CKD patients had a 31% higher risk of all-cause mortality (OR = 1.31, 95% CI: 1.01–1.70; p = 0.04) and a ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.